Enhancing Trauma Care Through Geospatial Strategies: Tailored Approaches to a Worldwide Challenge
-
By
-
Michael K. Dalton
-
Molly P. Jarman
-
September 29, 2026
By
Michael K. Dalton
Molly P. Jarman
September 29, 2026
by Michael K. Dalton, Molly P. Jarman
September 29, 2026
In the single-arm REFOCUS trial, 46% of patients responded to treatment, with a median response duration of 11.8 months.
September 24, 2026